Meet woman, who studied in US, now works in Rs 400000 crore company, daughter of India's richest... Kirti Kulhari admits ...

Indian drugmakers are hoping that bilateral discussions between the country and the United States will help them steer clear ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

But Dilip Shanghvi, 67, is no ordinary man. The child poring through medicine labels decided one fine day to make medicines himself, and became successful, way beyond probably what he himself ...

A key component of the transactions includes a $650 million funding arrangement for its U.S. subsidiary, Sun Pharmaceutical ...

Government data shows that the US is the biggest market for Indian drugmakers. The country, which boasts of being the ...

Sharing details of Sun Pharma's mergers and acquisitions (M&As) and strategic partnerships, Dilip Shanghvi said, "We are currently in the process of integrating Concert Pharmaceuticals that we ...

The 2-day Indian Pharma Alliance Conference concluded on Friday and speaking at the conference, Founder and MD of Sun Pharma, Dilip Shanghvi as well as Pankaj Patel of Zydus Cadila say that ...

The company relies on its key generic drugs in oncology and immunology therapies for sales in the region, which rose 28 per ...

Indian pharmaceutical and steel sectors show resilience against proposed US trade tariffs. Sun Pharma's Shanghvi indicates ...

U.S. President Donald Trump said on Tuesday he intends to impose a "25% or higher" levies on semiconductors and ...

In fiscal 2024, the exports to the U.S. were worth $8.7 billion, or about 31% of total pharma exports, per data from government-backed trade body Pharmexcil. Trump's threat to raise tariffs sent ...